Groupe Berkem

ALKEM

FR00140069V2

Pharmaceuticals

Real-time Euronext Paris Other stock markets 02:06:46 18/07/2024 pm IST			5-day change	1st Jan Change
2.89 ^EUR	+53.32%		+49.35%	-5.56%

13/05	Groupe Berkem Unveils BiombalanceTM and Pineol Premium, Two Active Ingredients from Its New Nutraceutical Range	CI
30/04	Groupe Berkem Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Groupe Berkem Société anonyme(ENXTPA:ALKEM) dropped from CAC AllShares Index

January 03, 2022 at 10:30 am IST

Groupe Berkem Société anonyme has been removed from CAC AllShares Index .

Latest news about Groupe Berkem

Groupe Berkem Unveils BiombalanceTM and Pineol Premium, Two Active Ingredients from Its New Nutraceutical Range	13/05	CI
Groupe Berkem Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	30/04	CI
Givaudan: agreement signed with Berkem	06/02	CF
Groupe Berkem to Buy Spanish Industrial Site from Givaudan	06/02	MT
Groupe Berkem Société anonyme Reports Unaudited Consolidated Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2023	06/02	CI
Groupe Berkem Société anonyme Provides Revenue Guidance for the Year 2025	06/02	CI
Groupe Berkem Société anonyme signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA .	06/02	CI
Groupe Berkem Société anonyme Postpones the Publication of Its 2023 Full-Year Revenue	31/01	CI
Groupe Berkem Extends Its H2olixir Range of 100% Natural Floral Waters	15/01	CI
Turkish inflation up to 62%, highest this year	04/12	RE
Groupe Berkem Announces the Launch of Novaterm, Its Connected and Boosted Anti-Termite Solution	26/23/26	CI
Groupe Berkem Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Groupe Berkem Société Anonyme Provides Revenue Guidance for the Year 2024	24/23/24	CI
Berkem: financial targets shifted by one year	16/23/16	CF
Everything's going (too?) well!	15/23/15
Groupe Berkem Launches Biombalance, Its New Range of Active Ingredients for the Nutraceuticals Market	14/23/14	CI
Groupe Berkem Société anonyme Announces Revenue Results for the First Half Ended June 30, 2023	31/23/31	CI
Groupe Berkem Société anonyme Provides Financial Guidance for the Year 2024	31/23/31	CI
Let's do it again, but without the same old stuff	31/23/31
Turkey policy moves are steps in right direction - EBRD official	21/23/21	RE
Groupe Berkem Mulls Merger of Four Main Units to Simplify Structure	22/23/22	MT
Groupe Berkem Considers Merging Its Main Subsidiaries	21/23/21	CI
France's Berkem to Form African Alkyd Resin Production JV with Dolidol	06/23/06	MT
Groupe Berkem Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	16/23/16	CI
Groupe Berkem Société Anonyme Provides Revenue Guidance for 2024	27/23/27	CI

Berkem Group is a chemical group organized around 4 business units: - production of active ingredients: from the extraction of plant materials. In addition, the group offers freeze-drying services for the food, cosmetics, nutraceutical and pharmaceutical industries, etc.; - formulation of solutions for the preservation and protection of materials: in particular wood materials; - distribution of solutions for the treatment, machining and protection of wood materials; - manufacture of alkyd resins: for the paint, construction, wood treatment and ink industries. At the end of 2023, the company has 3 production sites located in France. France accounts for 71.6% of net sales.

Sector

Pharmaceuticals

Calendar

25/07/2024 - Q2 2024 Sales and Revenue Release

More about the company

Income Statement Evolution

More financial data

Ratings for Groupe Berkem

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.885 EUR

Average target price

3.933 EUR

Spread / Average Target

+108.66%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
GROUPE BERKEM	-5.56%	36.27M
ELI LILLY AND COMPANY	+55.35%	815B
NOVO NORDISK A/S	+32.13%	597B
JOHNSON & JOHNSON	-0.10%	377B
MERCK & CO., INC.	+15.47%	319B
ABBVIE INC.	+13.10%	310B
ASTRAZENECA PLC	+16.49%	247B
NOVARTIS AG	+14.61%	228B
AMGEN INC.	+16.54%	180B
PFIZER, INC.	+4.31%	170B

Other Pharmaceuticals

Groupe Berkem

Equities

ALKEM

FR00140069V2

Pharmaceuticals

Groupe Berkem Société anonyme(ENXTPA:ALKEM) dropped from CAC AllShares Index

Latest news about Groupe Berkem

Chart Groupe Berkem

Company Profile

Income Statement Evolution

Ratings for Groupe Berkem

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals